“…Besides, liposomes have an advantage over other carriers since the components used for its production could be of low cost, which increases its commercial feasibility. The results of recent studies imply the efficacy of liposomes in protection, control of release and maintaining the bioactivities of hydrolysates or peptides from several sources like orange seed protein hydrolysate ( Mazloomi, et al, 2020 ), casein protein hydrolysate ( Sarabandi et al, 2019a ), flaxseed protein hydrolysate ( Sarabandi et al, 2019b ), fish protein hydrolysates ( Li et al, 2015 , Sepúlveda et al, 2021 ), whey protein hydrolysate ( Corrêa, et al, 2019 ), sunflower protein hydrolysate ( Luo, & He, 2018 ), Spirulina plantensis protein hydrolysate ( Mohammadi, et al, 2021 ), and others. Also, the use of liposomes improves organoleptic qualities, increases bioavailability and stability, and allows regulated release of bioactive peptides, with the magnitude of these improvements depending on the chemical nature of the encapsulated hydrolysate, and the liposome preparation and size reduction process utilized ( Corrêa et al, 2019 , Luo and He, 2018 , Sarabandi et al, 2019b , Sarabandi et al, 2019a , Sepúlveda et al, 2021 ).…”